Faeth Therapeutics, Inc. (FTH) Institutional Ownership and Insiders Activity

Faeth Therapeutics, Inc. (FTH) is widely held by institutional investors, with 48 firms reporting positions valued at approximately $331.14M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Suvretta Capital Management, Llc is the largest disclosed holder, reporting approximately $50.50M in FTH holdings in its latest filing.

Recent insider activity includes 1 tracked Form 4 transaction over the last three months, reflecting ongoing executive and director trading activity.